These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36877070)

  • 21. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of the mechanisms of SARS-CoV-2 evolution and transmission.
    Chen J; Wang R; Wei GW
    ArXiv; 2021 Sep; ():. PubMed ID: 34545334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.
    Kim YJ; Jang US; Soh SM; Lee JY; Lee HR
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33917138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Droplet digital RT-PCR to detect SARS-CoV-2 signature mutations of variants of concern in wastewater.
    Heijnen L; Elsinga G; de Graaf M; Molenkamp R; Koopmans MPG; Medema G
    Sci Total Environ; 2021 Dec; 799():149456. PubMed ID: 34371414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genomics and epidemiology of SARS-CoV-2 lineage].
    Sukegawa S; Takeuchi H
    Uirusu; 2021; 71(1):19-32. PubMed ID: 35526991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prevalence of Protein S Variant in Patients Diagnosed with COVID-19.
    Bayirli-Turan D; Usanmaz M; Gorgun S; Yolcu E; Sahin C; Bilenoglu O; Isbilen M; Yildiz E
    Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.
    Chakraborty C; Sharma AR; Bhattacharya M; Lee SS
    Front Immunol; 2022; 13():801522. PubMed ID: 35222380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.
    Tsai MS; Shih WT; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
    Biomed Pharmacother; 2022 May; 149():112802. PubMed ID: 35279013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants.
    Mertens J; Coppens J; Loens K; Le Mercier M; Xavier BB; Lammens C; Vandamme S; Jansens H; Goossens H; Matheeussen V
    Clin Microbiol Infect; 2022 Jan; 28(1):124-129. PubMed ID: 34537361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera.
    Seephetdee C; Bhukhai K; Buasri N; Leelukkanaveera P; Lerdwattanasombat P; Manopwisedjaroen S; Phueakphud N; Kuhaudomlarp S; Olmedillas E; Saphire EO; Thitithanyanont A; Hongeng S; Wongtrakoongate P
    Antiviral Res; 2022 Aug; 204():105370. PubMed ID: 35772601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A New Method to Detect Variants of SARS-CoV-2 Using Reverse Transcription Loop-Mediated Isothermal Amplification Combined with a Bioluminescent Assay in Real Time (RT-LAMP-BART).
    Iijima T; Sakai J; Kanamori D; Ando S; Nomura T; Tisi L; Kilgore PE; Percy N; Kohase H; Hayakawa S; Maesaki S; Hoshino T; Seki M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern.
    Pabbaraju K; Zelyas N; Wong A; Croxen MA; Lynch T; Buss E; Murphy S; Shokoples S; Kanji J; Tipples G
    J Virol Methods; 2022 Sep; 307():114553. PubMed ID: 35644262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.
    Schröder S; Richter A; Veith T; Emanuel J; Gudermann L; Friedmann K; Jeworowski LM; Mühlemann B; Jones TC; Müller MA; Corman VM; Drosten C
    Virol J; 2023 Nov; 20(1):257. PubMed ID: 37940989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinctive Combinations of RBD Mutations Contribute to Antibody Evasion in the Case of the SARS-CoV-2 Beta Variant.
    Kim TH; Bae S; Goo S; Myoung J
    J Microbiol Biotechnol; 2023 Dec; 33(12):1587-1295. PubMed ID: 37915256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.
    Saied AA; Nascimento MSL; do Nascimento Rangel AH; Skowron K; Grudlewska-Buda K; Dhama K; Shah J; Abdeen A; El-Mayet FS; Ahmed H; Metwally AA
    J Med Virol; 2022 Oct; 94(10):4599-4610. PubMed ID: 35655326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Variants: Mutations and Effective Changes.
    Park G; Hwang BH
    Biotechnol Bioprocess Eng; 2021; 26(6):859-870. PubMed ID: 34975266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.